Bert van Geel

1.3k total citations · 1 hit paper
7 papers, 896 citations indexed

About

Bert van Geel is a scholar working on Cancer Research, Genetics and Molecular Biology. According to data from OpenAlex, Bert van Geel has authored 7 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 4 papers in Genetics and 1 paper in Molecular Biology. Recurrent topics in Bert van Geel's work include Cancer Genomics and Diagnostics (4 papers), BRCA gene mutations in cancer (4 papers) and Breast Cancer Treatment Studies (2 papers). Bert van Geel is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), BRCA gene mutations in cancer (4 papers) and Breast Cancer Treatment Studies (2 papers). Bert van Geel collaborates with scholars based in Netherlands, Belgium and United States. Bert van Geel's co-authors include Jan G.M. Klijn, Caroline Seynaeve, Marian B. E. Menke‐Pluymers, Cecile T.M. Brekelmans, Carina C. M. Bartels, Sonja C. Henzen‐Logmans, Martinus F. Niermeijer, Ans M.W. van den Ouweland, Leon C. Verhoog and Hanne Meijers-Heijboer and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and European Journal of Cancer.

In The Last Decade

Bert van Geel

7 papers receiving 853 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Breast Cancer after Prophylactic Bilateral Mastectomy in Women with aBRCA1orBRCA2Mutation

2001 658 citations Bert van Geel, Sonja C. Henzen‐Logmans et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bert van Geel Netherlands	7	756	358	254	199	160	7	896
Leon C. Verhoog Netherlands	8	860 1.1×	411 1.1×	337 1.3×	251 1.3×	209 1.3×	9	1.1k
L.C. Verhoog Netherlands	11	1.1k 1.4×	539 1.5×	296 1.2×	334 1.7×	285 1.8×	16	1.3k
Carina C. M. Bartels Netherlands	11	962 1.3×	401 1.1×	358 1.4×	221 1.1×	186 1.2×	11	1.2k
C.C.M. Bartels Netherlands	10	723 1.0×	378 1.1×	301 1.2×	243 1.2×	198 1.2×	20	943
Kaylene Ready United States	15	486 0.6×	268 0.7×	180 0.7×	112 0.6×	163 1.0×	27	705
Lisa Jablon United States	4	468 0.6×	219 0.6×	137 0.5×	186 0.9×	164 1.0×	5	671
Kerstin Rhiem Germany	15	572 0.8×	312 0.9×	184 0.7×	175 0.9×	258 1.6×	28	786
Patrice Watson United States	8	365 0.5×	241 0.7×	398 1.6×	549 2.8×	125 0.8×	8	800
Lisa R. Susswein United States	15	575 0.8×	249 0.7×	192 0.8×	331 1.7×	236 1.5×	25	913
Johanna Lee United Kingdom	4	432 0.6×	221 0.6×	260 1.0×	318 1.6×	93 0.6×	5	712

Countries citing papers authored by Bert van Geel

Since Specialization

Citations

This map shows the geographic impact of Bert van Geel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert van Geel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert van Geel more than expected).

Fields of papers citing papers by Bert van Geel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bert van Geel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert van Geel. The network helps show where Bert van Geel may publish in the future.

Co-authorship network of co-authors of Bert van Geel

This figure shows the co-authorship network connecting the top 25 collaborators of Bert van Geel. A scholar is included among the top collaborators of Bert van Geel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bert van Geel. Bert van Geel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Kriege, Mieke, Caroline Seynaeve, Hanne Meijers-Heijboer, et al.. (2009). Sensitivity to First-Line Chemotherapy for Metastatic Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. Journal of Clinical Oncology. 27(23). 3764–3771. 77 indexed citations

2.

Kriege, Mieke, Caroline Seynaeve, Hanne Meijers‐Heijboer, et al.. (2007). Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patients. Breast Cancer Research and Treatment. 111(2). 303–311. 25 indexed citations

3.

Meijers-Heijboer, Hanne, Cecile T.M. Brekelmans, Marian B. E. Menke‐Pluymers, et al.. (2003). Use of Genetic Testing and Prophylactic Mastectomy and Oophorectomy in Women With Breast or Ovarian Cancer From Families With a BRCA1 or BRCA2 Mutation. Journal of Clinical Oncology. 21(9). 1675–1681. 103 indexed citations

4.

Geel, Bert van, Sonja C. Henzen‐Logmans, Caroline Seynaeve, et al.. (2001). Breast Cancer after Prophylactic Bilateral Mastectomy in Women with aBRCA1orBRCA2Mutation. New England Journal of Medicine. 345(3). 159–164. 658 indexed citations breakdown →

5.

Koops, H. Schraffordt, et al.. (1993). Isolated limb perfusion (ILP) with high dose TNF-α, gamma-IFN and melphalan in patients with irresectable soft tissue sarcomas: A highly effective limb saving procedure. European Journal of Cancer. 29. S183–S183. 10 indexed citations

6.

Geel, Bert van, et al.. (1991). The relation between pharmacokinetics and endocrine effects of buserelin implants in patients with mastalgia. Clinical Endocrinology. 34(4). 253–258. 9 indexed citations

7.

Fentiman, I S, Jean‐Pierre Julien, J.A. van Dongen, et al.. (1991). Reasons for non-entry of patients with DCIS of the breast into a randomised trial (EORTC 10853). European Journal of Cancer and Clinical Oncology. 27(4). 451–452. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact